ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,205, issued on Aug. 26, was assigned to Elixiron Immunotherapeutics (Hong Kong) Ltd. (Central Hong Kong, China).
"Anti-interferon gamma antibodies and uses thereof" was invented by Cheng-Lun Ku (Taoyuan, Taiwan), Han-Po Shih (Taoyuan, Taiwan), Chia-Hao Lin (New Taipei, Taiwan), Jing-Ya Ding (Taoyuan, Taiwan), Jing-Yi Huang (Taipei, Taiwan) and Yi-Ting Kuo (Taichung, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an anti-INF-Gamma antibody. Also provided are a composition comprising the antibody and a pharmaceutical application of the antibody in treating IFN-Gamma mediated syndrome."
The patent was filed on Feb. 12, 2021, under A...